What explains gray matter atrophy in long-standing multiple sclerosis?

Martijn D. Steenwijk*, Marita Daams, Petra J.W. Pouwels, Lisanne J. Balk, Prejaas K. Tewarie, Joep Killestein, Bernard M.J. Uitdehaag, Jeroen J.G. Geurts, Frederik Barkhof, Hugo Vrenken

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

67 Citations (Scopus)


Purpose: To identify the measures of focal and diffuse white matter (WM) abnormalities that are related to whole-brain, deep, and cortical gray matter (GM) atrophy in long-standing multiple sclerosis (MS). Materials and Methods: The institutional review board approved the study; all subjects gave written informed consent. Magnetic resonance (MR) imaging was performed at 3 T in 208 patients with MS of long-standing duration (disease duration ≥ 10 years) and in 60 healthy control subjects. Normalized GM volume (NGMV), normalized WM volume (NWMV), normalized deep GM volume (NDGMV), cortical thickness, and normalized lesion volume (NLV) were quantified. Tissue integrity of normal-appearing WM (NAWM) and lesions was measured by using diffusion-tensor MR imaging. Multivariate associations between measures of GM atrophy and WM abnormalities were assessed in the patient group by using multiple linear regression. Results: NGMV, NDGMV, and cortical thickness were reduced in patients with MS (all P < .001). The final model for NGMV consisted of NWMV, NLV, and patient age and sex (adjusted R2 = 0.58, P < .001). NWMV, NLV, and patient sex were the explanatory variables for NDGMV (adjusted R 2 = 0.75, P < .001). The model for cortical thickness consisted of fractional anisotropy of NAWM, NLV, and patient age and sex (adjusted R 2 = 0.32, P < .001). The relationship between GM atrophy and WM abnormalities was weaker in primary and secondary progressive disease than in relapsing-remitting disease. Conclusion: Whole-brain and deep GM atrophy were particularly explained by WM a=ociated with NAWM integrity loss. The weaker relationship between GM atrophy and WM abnormalities in patients with progressive disease might indicate a more independent neurodegenerative disease process in these patients.

Original languageEnglish
Pages (from-to)832-842
Number of pages11
Issue number3
Publication statusPublished - Sept 2014
Externally publishedYes


  • n/a OA procedure


Dive into the research topics of 'What explains gray matter atrophy in long-standing multiple sclerosis?'. Together they form a unique fingerprint.

Cite this